These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38561102)
1. Resveratrol protects cardiomyocytes against ischemia/reperfusion-induced ferroptosis via inhibition of the VDAC1/GPX4 pathway. Hu T; Zou HX; Zhang ZY; Wang YC; Hu FJ; Huang WX; Liu JC; Lai SQ; Huang H Eur J Pharmacol; 2024 May; 971():176524. PubMed ID: 38561102 [TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA confers protection against myocardial ischemia/reperfusion injury by inhibiting ferroptosis and apoptosis via VDAC1. Hu T; Zou HX; Le SY; Wang YR; Qiao YM; Yuan Y; Liu JC; Lai SQ; Huang H Int J Mol Med; 2023 Nov; 52(5):. PubMed ID: 37800609 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis. Li T; Tan Y; Ouyang S; He J; Liu L Gene; 2022 Jan; 808():145968. PubMed ID: 34530090 [TBL] [Abstract][Full Text] [Related]
4. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol protects cardiomyocytes against anoxia/reoxygenation via dephosphorylation of VDAC1 by Akt-GSK3 β pathway. Tian M; Xie Y; Meng Y; Ma W; Tong Z; Yang X; Lai S; Zhou Y; He M; Liao Z Eur J Pharmacol; 2019 Jan; 843():80-87. PubMed ID: 30445019 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol reduces ROS-induced ferroptosis by activating SIRT3 and compensating the GSH/GPX4 pathway. Wang X; Shen T; Lian J; Deng K; Qu C; Li E; Li G; Ren Y; Wang Z; Jiang Z; Sun X; Li X Mol Med; 2023 Oct; 29(1):137. PubMed ID: 37858064 [TBL] [Abstract][Full Text] [Related]
7. Galangin Attenuates Myocardial Ischemic Reperfusion-Induced Ferroptosis by Targeting Nrf2/Gpx4 Signaling Pathway. Yang T; Liu H; Yang C; Mo H; Wang X; Song X; Jiang L; Deng P; Chen R; Wu P; Chen A; Yan J Drug Des Devel Ther; 2023; 17():2495-2511. PubMed ID: 37637264 [TBL] [Abstract][Full Text] [Related]
8. Connexin43 overexpression promoted ferroptosis and increased myocardial vulnerability to ischemia-reperfusion injury in type 1 diabetic mice. Yang Y; Chen J; Zhou J; Zhou D; Zhang A; Jiang Y; Lin J; Xia W; Cai Y; Han R; Lu Y; Liu D; Xia Z Int J Med Sci; 2024; 21(12):2365-2378. PubMed ID: 39310260 [TBL] [Abstract][Full Text] [Related]
9. Activation of PPAR-α attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis and mitochondrial injury via upregulating 14-3-3η. Hu T; Yu WP; Wang XQ; Wang ZY; Xu ZQ; Hu FJ; Liu JC; Yu F; Wang LJ Sci Rep; 2024 Jul; 14(1):15246. PubMed ID: 38956068 [TBL] [Abstract][Full Text] [Related]
10. Liproxstatin-1 protects the mouse myocardium against ischemia/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels. Feng Y; Madungwe NB; Imam Aliagan AD; Tombo N; Bopassa JC Biochem Biophys Res Commun; 2019 Dec; 520(3):606-611. PubMed ID: 31623831 [TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate confers protection against myocardial ischemia/reperfusion injury by inhibiting ferroptosis, apoptosis, and autophagy via modulation of 14-3-3η. Hu T; Hu FJ; Huang H; Zhang ZY; Qiao YM; Huang WX; Wang YC; Tang XY; Lai SQ Biomed Pharmacother; 2024 May; 174():116542. PubMed ID: 38574620 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol alleviated 5-FU-induced cardiotoxicity by attenuating GPX4 dependent ferroptosis. Li D; Song C; Zhang J; Zhao X J Nutr Biochem; 2023 Feb; 112():109241. PubMed ID: 36442718 [TBL] [Abstract][Full Text] [Related]
13. Regulation of VDAC1 contributes to the cardioprotective effects of penehyclidine hydrochloride during myocardial ischemia/reperfusion. Lin D; Cui B; Ren J; Ma J Exp Cell Res; 2018 Jun; 367(2):257-263. PubMed ID: 29630893 [TBL] [Abstract][Full Text] [Related]
14. Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis Chen W; Zhang Y; Wang Z; Tan M; Lin J; Qian X; Li H; Jiang T Front Pharmacol; 2023; 14():1078205. PubMed ID: 36891270 [TBL] [Abstract][Full Text] [Related]
15. Fucoxanthin alleviated myocardial ischemia and reperfusion injury through inhibition of ferroptosis Yan J; Li Z; Liang Y; Yang C; Ou W; Mo H; Tang M; Chen D; Zhong C; Que D; Feng L; Xiao H; Song X; Yang P Food Funct; 2023 Nov; 14(22):10052-10068. PubMed ID: 37861458 [No Abstract] [Full Text] [Related]
16. Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion-induced ferroptosis via the keap1/Nrf2/GPX4 signaling pathway. Zhong G; Chen J; Li Y; Han Y; Wang M; Nie Q; Xu M; Zhu Q; Chang X; Wang L BMC Complement Med Ther; 2024 Jun; 24(1):247. PubMed ID: 38926825 [TBL] [Abstract][Full Text] [Related]
17. Puerarin Protects against Myocardial Ischemia/Reperfusion Injury by Inhibiting Ferroptosis. Ding Y; Li W; Peng S; Zhou G; Chen S; Wei Y; Xu J; Gu H; Li J; Liu S; Liu B Biol Pharm Bull; 2023 Apr; 46(4):524-532. PubMed ID: 36696989 [TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis. Wang Z; Yao M; Jiang L; Wang L; Yang Y; Wang Q; Qian X; Zhao Y; Qian J Biomed Pharmacother; 2022 Oct; 154():113572. PubMed ID: 35988428 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of DYRK1a in myocardial ischemia-reperfusion injury by regulating ferroptosis of cardiomyocytes. Wang J; Xu RM; Cao QM; Ma BC; Zhang H; Hao HP Kaohsiung J Med Sci; 2023 Dec; 39(12):1190-1199. PubMed ID: 37702441 [TBL] [Abstract][Full Text] [Related]